Last reviewed · How we verify

NCT06139809: IntubAID

Noninvasive Positive Pressure Ventilation During Neonatal Nasal Intubation

Completed NA Last updated 18 November 2025
What this trial tests

NA trial testing Intubation in Infant, Newborn, Diseases in 50 participants. Completed in 5 October 2025.

Timeline
31 March 2024
Primary endpoint
5 October 2025
5 October 2025

Quick facts

Lead sponsorUniversity of Zurich
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationna
Designsingle group
Maskingnone
Primary purposeother
Enrollment50
Start date31 March 2024
Primary completion5 October 2025
Estimated completion5 October 2025
Sites1 location across Switzerland

Drugs / interventions tested

Conditions studied

Sponsor

University of Zurich

Who can join

Eligibility, any sex, with Infant, Newborn, Diseases or Intubation Complication. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The goal of this study is to perform a quality control assessment of our local intubation protocol in any newborn infant requiring endotracheal intubation in the delivery room or neonatal intensive care unit at the Department of Neonatology of the University Hospital Zurich. The primary aims are: * Successful nasal intubation at the first attempt without physiological instability. * Comparison of infants with successful intubation at the first attempt without physiological instability to the infants in the SHINE-Trial in Australia. Participants will be intubated according to our standard intubation procedure using non-invasive ventilation (NIV) delivered through a nasopharyngeal tube.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of Intubation

Trials testing the same drug.

Other recruiting trials for Infant, Newborn, Diseases

Currently open trials in the same condition.

Other University of Zurich trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06139809.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing